title: Which antibiotic for hospital acquired pneumonia caused by MRSA?
authors: Queen's University, Kingston, ON, Canada, K7L 2V7.
authors: John
authors: J
authors: Muscedere
mesh_terms: D000081:Acetamides / Q000627:therapeutic use; D000617:Aminoglycosides / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy*; D017576:Daptomycin / Q000627:therapeutic use; D006801:Humans; D000069349:Linezolid; D000077427:Lipoglycopeptides; D055624:Methicillin-Resistant Staphylococcus aureus; D008911:Minocycline / Q000031:analogs & derivatives / Q000627:therapeutic use; D023303:Oxazolidinones / Q000627:therapeutic use; D011023:Pneumonia, Staphylococcal / Q000188:drug therapy* / Q000382:microbiology; D000078304:Tigecycline; D014640:Vancomycin / Q000627:therapeutic use; D014769:Virginiamycin / Q000627:therapeutic use; D000097583:Ceftaroline
chemical_list: D000081:Acetamides; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D017576:Daptomycin; D000069349:Linezolid; D000077427:Lipoglycopeptides; D008911:Minocycline; D023303:Oxazolidinones; D000078304:Tigecycline; D014640:Vancomycin; D014769:Virginiamycin; D000097583:Ceftaroline; C062940:quinupristin-dalfopristin; C487637:telavancin